Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
AUTOR(ES)
Tuon, Felipe Francisco, Santos, Carolina Rocio, Cieslinski, Juliette, Souza, Regina Maia de, Imamura, Rui, Amato, Valdir Sabbaga
FONTE
Rev. Inst. Med. trop. S. Paulo
DATA DE PUBLICAÇÃO
08/11/2018
RESUMO
Documentos Relacionados
- Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.
- Efficacious Treatment of Experimental Leishmaniasis with Amphotericin B-Arabinogalactan Water-Soluble Derivatives
- Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres
- Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis
- Efficacious Topical Treatment for Murine Cutaneous Leishmaniasis with Ethanolic Formulations of Amphotericin B
